Myofascial Release of Physiological Chains and Muscle Stretching in Patients With Fibromyalgia

NCT03408496 | Completed

• 1 other identifier: NSchulze
• Study Type: interventional
• Target: 38
• Locations: 1 country
• Sites: 1

Brief Summary

Muscle stretching is a therapeutic technique commonly used by physiotherapists, but for the treatment of fibromyalgia it still has weak evidence to support its real effect. On the other hand, myofascial mobilization in the location of tender points, as it is the solution for the population, demonstrating effects on the improvement of the symptoms, but not yet achieving the minimal clinically important change. In this context, myofascial release guided by physiological chains, so far not studied, is presented as an alternative to improve pain and quality of life in patients with fibromyalgia because it acts in a global way and, probably, more effective. This study evaluates the effect of myofascial release of the trunk physiological chains and muscle stretching on pain, quality of life and functional capacity of patients with fibromyalgia when compared to the control group.

Conditions

Fibromyalgia

Keywords

Myofascial release; Pain; Manual therapy; Muscle stretching; Quality of life

Outcome Measures

Primary Outcomes (2)

• Pain intensity level change

  Self reported pain intensity measured by the Visual Analog Scale, wich ranges from 0 to 10, where 0 means absence of pain and 10 means the worst pain already felt

  Baseline, after 4 weeks since the beginning of the treatment, after 8 weeks since the beginning of the treatment, follow-up (after 12 weeks since the beginning of the treatment)

• Quality of life score change

  Evaluated by the Fibromyalgia Impact Questionnaire, wich evaluates aspects of functional capacity, work status, psychological disturbances and physical symptoms. The total score ranges from 0 to 100, where higher scores have a worst impact of fibromyalgia on quality of life and functional capacity.

  Baseline, after 4 weeks since the beginning of the treatment, after 8 weeks since the beginning of the treatment, follow-up (after 12 weeks since the beginning of the treatment)

Secondary Outcomes (1)

• Amount of analgesic ingested

  Up to 12 weeks

Study Arms (3)

Myofascial release

EXPERIMENTAL

Eight consecutive weekly sessions lasting 40-45 minutes of myofascial release of the trunk physiological chains. The connective tissue of the flexion chain and the posterior static chain will be released. The myofascial release will be obtained through the mechanical effect produced by the friction of the therapist's hand with a surface of the patient's body, which is performed through "traces" executed with the fingers (thumb supported or middle finger on the indicator to achieve effect local) following as addressed chains. The release will be repeated until the feeling of local relaxation of the tissue.

Other: Myofascial release

Muscle Stretching

EXPERIMENTAL

The muscle stretching protocol described by Bressan (2008) will be followed, which consists of 8 consecutive weekly sessions, lasting 40-45 minutes. In dorsal decubitus or sitting, the triceps surae, hamstring, gluteal, paravertebral, latissimocondyloideus, pectoral, trapezius and respiratory muscles will be stretched. The exercises will be performed in a series of five repetitions for 30 seconds.

Other: Muscle stretching

Control

ACTIVE COMPARATOR

It will perform only the treatment prescribed by the responsable doctor, wich can be the use of drug and/or psychological treatment, and will be followed clinically by a rheumatologist during four medical appointments to monitor medication and follow in the analgesic's diary, according the standard procedure of attending the hospital where the patients will be recruited.

Other: Control

Interventions

Myofascial release OTHER

Manual therapy

Myofascial release

Muscle stretching OTHER

Muscle stretching

Muscle Stretching

Control OTHER

Medical appointment

Control

Eligibility Criteria

• Age: 18 Years - 59 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Confirmation of the diagnosis by rheumatologists according to the diagnostic criteria established by the American College of Rheumatology of 1990 and 2010.
• Moderate to severe pain according to the Fibromyalgia Impact Questionnaire (≥ 4).
• Prescribed treatment (drug and/or psychological) stable in the last month before the selection for those who perform.
• Patients who live in the metropolitan area of Recife - Pernambuco, Brazil.

You may not qualify if:

• Nonpharmacologic therapies, except for psychological treatment if prescribed by the doctor at the same time of the study.
• Skin diseases.
• Patients classified as "very active" by the International Physical Activity Questionnaire.
• Women who use intrauterine devices (IUD).
• Pregnant women.
• Patients with other associated rheumatic disease or with modified posture due to congenital anatomic alteration.
• Severe decompensated comorbidities (cancer, thyroid disease and diabetes).
• Infection, fever, hypotension, respiratory alterations limiting treatment.
• Cardiovascular event in the previous year.
• Presence of cardiac, renal or hepatic insufficiency.
• Arterial or peripheral venous insufficiency.
• Presence of a hypertrophic scar on the trunk.
• Obesity grade 3.
• Illiteracy.
• Severe psychiatric illness.

Sponsors & Collaborators

• Universidade Federal de Pernambuco: lead

Study Sites (1)

Universidade Federal de Pernambuco

Recife, Pernambuco, 50740-560, Brazil

Location

MeSH Terms

Conditions

Fibromyalgia; Pain

Interventions

Myofascial Release Therapy; Muscle Stretching Exercises

Condition Hierarchy (Ancestors)

Muscular Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Neuromuscular Diseases; Nervous System Diseases; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Massage; Therapy, Soft Tissue; Musculoskeletal Manipulations; Complementary Therapies; Therapeutics; Physical Therapy Modalities; Rehabilitation; Exercise Therapy; Aftercare; Continuity of Patient Care; Patient Care; Exercise; Motor Activity; Movement; Musculoskeletal Physiological Phenomena; Musculoskeletal and Neural Physiological Phenomena

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Model Details: Participants will be allocated in 3 groups. The myofascial release group, muscle stretching group and control group.

Study Record Dates

• First Submitted: January 7, 2018
• First Posted: January 24, 2018
• Study Start: January 23, 2018
• Primary Completion: February 16, 2019
• Study Completion: March 19, 2019
• Last Updated: March 21, 2019

Record last verified: 2018-09

Locations

BR (1)